Fraxinol
CAS No. 486-28-2
Fraxinol ( —— )
Catalog No. M19428 CAS No. 486-28-2
Fraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 119 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFraxinol
-
NoteResearch use only not for human use.
-
Brief DescriptionFraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one.
-
DescriptionFraxinol is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 5 7-dimethoxy-2h-chromen-2-one. It is generated by cyp1a2 cyp2a6 cyp2b6 cyp2c9 cyp2c19 and cyp2e1 enzymes via an aromatic-hydroxylation-of-fused-benzene-ring-pattern1 reaction.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number486-28-2
-
Formula Weight222.2
-
Molecular FormulaC11H10O5
-
Purity>98% (HPLC)
-
SolubilityChloroform Dichloromethane Ethyl Acetate Acetone etc.:Soluble;DMSO:Soluble
-
SMILESCOC1=C(C(=C2C=CC(=O)OC2=C1)OC)O
-
Chemical Name2H-1-Benzopyran-2-one 6-hydroxy-57-dimethoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hammoda H. Ela M. El-Lankany A. El-Hanbali O. Zaki C. & Ghazy N. (2008). New constituents of Artemisia monosperma Del.?Pharmazie.?63(8) 611-4.
molnova catalog
related products
-
Thifensulfuron-methy...
Thifensulfuron-methyl is a sulfonylurea (SU) herbicide, has an important role in the removal of broadleaf weeds.
-
Plantanone B
Plantanone C exhibited moderate antioxidant activity against DPPH radical scavenging activity,with an IC50 value of 240. 2 μmol·L~(-1).
-
BMS-P5 free base
BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor.?BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.